Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Prometheus Biosciences Inc (RXDX)

Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Prometheus Biosciences Inc. is a biotechnology company. It involved in the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory bowel disease. Prometheus Biosciences Inc. is based in SAN DIEGO.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2022 Dec, 2021 Dec, 2020 Dec, 2019 Dec, 2012
Sales 6,810 3,130 1,230 1,120 0
Sales Growth +117.57% +154.47% +9.82% unch unch
Net Income -141,750 -90,200 -37,140 -29,720 -1,270
Net Income Growth -57.15% -142.86% -24.97% -2,240.16% unch

Balance Sheet

(Values in U.S. Thousands) Dec, 2022 Dec, 2021 Dec, 2020 Dec, 2019 Dec, 2012
Total Assets 740,770 267,800 59,630 50,480 5,440
Total Assets Growth +176.61% +349.10% +18.13% +827.94% unch
Total Liabilities 64,810 32,650 31,150 43,710 880
Total Liabilities Growth +98.50% +4.82% -28.73% +4,867.05% unch

Cash Flow

(Values in U.S. Thousands) Dec, 2022 Dec, 2021 Dec, 2020 Dec, 2019 Dec, 2012
Operating Cash Flow -123,250 -63,510 -28,020 -20,200 -990
Operating Cash Flow Growth -94.06% -126.66% -38.71% -1,940.40% unch
Net Cash Flow 35,170 203,050 50,810 -2,510 4,870
Change in Net Cash Flow -82.68% +299.63% +2,124.30% -151.54% unch
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot